Cargando…
Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018)
PURPOSE: Multi-drug resistant Klebsiella pneumoniae (MDR KP) is spreading worldwide and has posed a huge medical burden to public health. However, studies on drug resistance surveillance of KP, especially MDR KP, with a large longitudinal sample size in a tertiary hospital are rare. This study aims...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898056/ https://www.ncbi.nlm.nih.gov/pubmed/33628037 http://dx.doi.org/10.2147/IDR.S294989 |
_version_ | 1783653793259323392 |
---|---|
author | Pei, Na Liu, Qingxia Cheng, Xinyi Liang, Tianzhu Jian, Zijuan Wang, Siyi Zhong, Yiming He, Jingxuan Zhou, Mao Kristiansen, Karsten Chen, Weijun Liu, Wenen Li, Junhua |
author_facet | Pei, Na Liu, Qingxia Cheng, Xinyi Liang, Tianzhu Jian, Zijuan Wang, Siyi Zhong, Yiming He, Jingxuan Zhou, Mao Kristiansen, Karsten Chen, Weijun Liu, Wenen Li, Junhua |
author_sort | Pei, Na |
collection | PubMed |
description | PURPOSE: Multi-drug resistant Klebsiella pneumoniae (MDR KP) is spreading worldwide and has posed a huge medical burden to public health. However, studies on drug resistance surveillance of KP, especially MDR KP, with a large longitudinal sample size in a tertiary hospital are rare. This study aims to investigate phenotypic epidemiology characteristics of 4128 KP isolates in a Chinese tertiary hospital covering a period of 5 years. METHODS: All the KP clinical isolates were retrospectively collected from a tertiary hospital in Hunan province of China from Jan 5, 2013 to Jul 24, 2018. All the isolates were identified by MALDI-TOF MS analysis. Twenty-four antimicrobial agents were tested by antimicrobial susceptibility testing. Fisher exact test and logistic regression were used to analyze the association between clinical factors and antimicrobial non-susceptibility for seven second-choice antimicrobials. RESULTS: A total of 4128 KP isolates were collected in our study. The non-susceptible rates (NSRs) to ertapenem, imipenem and tigecycline increased considerably from 2013 to 2018 (13.6% to 28.6%, 10.1% to 28.9%, 10.8% to 46.5%, respectively). Amikacin presents the lowest NSR among 3 aminoglycosides (3.8–22.8%). The multi-drug NSRs among KP isolates to second-choice antimicrobials (88.6–100%) were higher than to all drugs (68.0%). The NSRs varied significantly among departments and sample sources. Higher ETP/IPM/AK NSRs (39.8/39.7/30.6%) were observed in Intensive Care Unit, and ETP/IPM non-susceptible isolates tended to distribute in cerebrospinal fluid. From 2015 to 2017, the NSRs of ETP, IPM, and AK showed an opposite trend of seasonal fluctuations to SXT. CONCLUSION: Higher multi-drug resistance (MDR) rates were observed in KP isolates to second-choice antimicrobials than to others, among which MDR rates to carbapenems or AK are the highest. A unique pattern of MIC and time distributions of MDR were observed. Clinical factors including gender were correlated with MDR rates of KP. Isolates in ICU and CSF showed higher NSRs in carbapenems which should be paid more attention to, and temporal distribution of NSRs was observed. |
format | Online Article Text |
id | pubmed-7898056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78980562021-02-23 Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) Pei, Na Liu, Qingxia Cheng, Xinyi Liang, Tianzhu Jian, Zijuan Wang, Siyi Zhong, Yiming He, Jingxuan Zhou, Mao Kristiansen, Karsten Chen, Weijun Liu, Wenen Li, Junhua Infect Drug Resist Original Research PURPOSE: Multi-drug resistant Klebsiella pneumoniae (MDR KP) is spreading worldwide and has posed a huge medical burden to public health. However, studies on drug resistance surveillance of KP, especially MDR KP, with a large longitudinal sample size in a tertiary hospital are rare. This study aims to investigate phenotypic epidemiology characteristics of 4128 KP isolates in a Chinese tertiary hospital covering a period of 5 years. METHODS: All the KP clinical isolates were retrospectively collected from a tertiary hospital in Hunan province of China from Jan 5, 2013 to Jul 24, 2018. All the isolates were identified by MALDI-TOF MS analysis. Twenty-four antimicrobial agents were tested by antimicrobial susceptibility testing. Fisher exact test and logistic regression were used to analyze the association between clinical factors and antimicrobial non-susceptibility for seven second-choice antimicrobials. RESULTS: A total of 4128 KP isolates were collected in our study. The non-susceptible rates (NSRs) to ertapenem, imipenem and tigecycline increased considerably from 2013 to 2018 (13.6% to 28.6%, 10.1% to 28.9%, 10.8% to 46.5%, respectively). Amikacin presents the lowest NSR among 3 aminoglycosides (3.8–22.8%). The multi-drug NSRs among KP isolates to second-choice antimicrobials (88.6–100%) were higher than to all drugs (68.0%). The NSRs varied significantly among departments and sample sources. Higher ETP/IPM/AK NSRs (39.8/39.7/30.6%) were observed in Intensive Care Unit, and ETP/IPM non-susceptible isolates tended to distribute in cerebrospinal fluid. From 2015 to 2017, the NSRs of ETP, IPM, and AK showed an opposite trend of seasonal fluctuations to SXT. CONCLUSION: Higher multi-drug resistance (MDR) rates were observed in KP isolates to second-choice antimicrobials than to others, among which MDR rates to carbapenems or AK are the highest. A unique pattern of MIC and time distributions of MDR were observed. Clinical factors including gender were correlated with MDR rates of KP. Isolates in ICU and CSF showed higher NSRs in carbapenems which should be paid more attention to, and temporal distribution of NSRs was observed. Dove 2021-02-17 /pmc/articles/PMC7898056/ /pubmed/33628037 http://dx.doi.org/10.2147/IDR.S294989 Text en © 2021 Pei et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Pei, Na Liu, Qingxia Cheng, Xinyi Liang, Tianzhu Jian, Zijuan Wang, Siyi Zhong, Yiming He, Jingxuan Zhou, Mao Kristiansen, Karsten Chen, Weijun Liu, Wenen Li, Junhua Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title | Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title_full | Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title_fullStr | Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title_full_unstemmed | Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title_short | Longitudinal Study of the Drug Resistance in Klebsiella pneumoniae of a Tertiary Hospital, China: Phenotypic Epidemiology Analysis (2013–2018) |
title_sort | longitudinal study of the drug resistance in klebsiella pneumoniae of a tertiary hospital, china: phenotypic epidemiology analysis (2013–2018) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898056/ https://www.ncbi.nlm.nih.gov/pubmed/33628037 http://dx.doi.org/10.2147/IDR.S294989 |
work_keys_str_mv | AT peina longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT liuqingxia longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT chengxinyi longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT liangtianzhu longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT jianzijuan longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT wangsiyi longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT zhongyiming longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT hejingxuan longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT zhoumao longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT kristiansenkarsten longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT chenweijun longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT liuwenen longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 AT lijunhua longitudinalstudyofthedrugresistanceinklebsiellapneumoniaeofatertiaryhospitalchinaphenotypicepidemiologyanalysis20132018 |